Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Antibiotics vs Active Observation for Uncomplicated Acute Appendicitis
NCT03985514Phase 4Completed
- Sponsor
- University of Gothenburg
- Start
- May 2018
- Primary completion
- Jun 2021
- Modality
- Irreversible Covalent Inhibitors
- Countries
- 1
01
Overview
Phase 4, randomised, open-label trial of piperacillin + tazobactam, ciprofloxacin and metronidazole in acute appendicitis (2 arms), sponsored by University of Gothenburg. Primary endpoint: Number of participants with no symptom relief at 48 hours. Started May 2018; status: completed.
02
Drugs
piperacillin + tazobactamciprofloxacinmetronidazole
03
Conditions
acute appendicitis
Beyond the preview
Go deeper on NCT03985514.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03985514.